It’s bonkers.” Roche is not a newcomer to the sequencing space: the company bought Jonathan Rothberg’s 454 in 2007 for $140 million. 454 had just announced the completion of Jim Watson’s ...

MiSeq and 454 GS Junior launched by Life Technologies, Illumina and Roche, respectively. Compared to the high-throughput NGS platforms, these benchtop sequencers offer a lower data throughput ...

and a few others unpack the facility's first next-generation sequencing machine, a 454 GS FLX, on loan from Roche Diagnostics for three months. They train for a few days, nebulize a colleague's ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...

After extension, the sequencing adaptors enable amplification ... We modified transposon ends to contain Roche/454-compatible tags (A and B). After the tagging and fragmenting reaction, we heat ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer ...

Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run for its money. Illumina has long ...

At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.

Basel, 20 February 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled today its proprietary, breakthrough sequencing by expansion (SBX) technology, establishing a new category of next-generation ...